DBD Logo

DBD Stock Forecast: Diebold Nixdorf Inc. Price Predictions for 2025

Home โ€บ Stocks โ€บ United States | NYSE | Technology | Software - Application

$42.64

+0.91 (2.18%)

DBD Stock Forecast 2025-2026

$42.64
Current Price
$1.60B
Market Cap
2 Ratings
Buy 2
Hold 0
Sell 0
Wall St Analyst Ratings

Distance to DBD Price Targets

+87.6%
To High Target of $80.00
+64.2%
To Median Target of $70.00
+40.7%
To Low Target of $60.00

DBD Price Momentum

-2.5%
1 Week Change
-8.5%
1 Month Change
+53,200.0%
1 Year Change
-0.9%
Year-to-Date Change
-17.7%
From 52W High of $51.81
+24.0%
From 52W Low of $34.38

๐Ÿค” Considering Diebold Nixdorf (DBD)?

Join 5,000+ investors getting our exclusive market analysis every Monday & Thursday. Stay ahead of breakout opportunities.

Latest DBD Stock Price Targets & Analyst Predictions

Based on our analysis of 8 Wall Street analysts, DBD has a bullish consensus with a median price target of $70.00 (ranging from $60.00 to $80.00). Currently trading at $42.64, the median forecast implies a 64.2% upside. This outlook is supported by 2 Buy, 0 Hold, and 0 Sell ratings.

The most optimistic forecast comes from Matthew Summerville at DA Davidson, projecting a 87.6% upside.

Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.

DBD Analyst Ratings

2
Buy
0
Hold
0
Sell

DBD Price Target Range

Low
$60.00
Average
$70.00
High
$80.00
Current: $42.64

Latest DBD Stock Forecasts by Analyst

These are the latest 20 analyst ratings and price targets for DBD.

Date Firm Analyst Rating Change Price Target
Feb 27, 2025 DA Davidson Matthew Summerville Buy Maintains $80.00
Sep 12, 2024 Wedbush Matt Bryson Outperform Reiterates $50.00
Aug 9, 2024 DA Davidson Matthew Summerville Buy Maintains $65.00
Aug 8, 2024 Wedbush Matt Bryson Outperform Reiterates $50.00
Jul 25, 2024 Wedbush Matt Bryson Outperform Reiterates $50.00
May 3, 2024 Wedbush Matt Bryson Outperform Upgrade $50.00
Apr 25, 2024 Wedbush Matt Bryson Neutral Reiterates $40.00
Feb 15, 2024 Wedbush Matt Bryson Neutral Maintains $40.00
Feb 12, 2024 Wedbush Matt Bryson Neutral Reiterates $25.00
Nov 10, 2023 Wedbush Matt Bryson Neutral Maintains $25.00
Nov 10, 2023 DA Davidson Matthew Summerville Buy Upgrade $29.00
Oct 30, 2023 Wedbush Matt Bryson Neutral Reiterates $20.00
Aug 18, 2023 Wedbush Matt Bryson Neutral Maintains $20.00
Aug 15, 2023 DA Davidson Matthew Summerville Neutral Reinstates $25.00
May 4, 2023 Wedbush Matt Bryson Neutral Downgrade $1.00
Mar 17, 2023 Wedbush Matt Bryson Outperform Reiterates $5.00
Oct 24, 2022 DA Davidson Matthew Summerville Neutral Downgrade $3.00
Aug 12, 2022 JP Morgan Paul Chung Underweight Downgrade $0.00
Jul 8, 2022 Wedbush Outperform Upgrade $0.00
Jun 21, 2021 Wedbush Neutral Initiates $0.00

Diebold Nixdorf Inc. (DBD) Competitors

The following stocks are similar to Diebold Nixdorf based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.

Diebold Nixdorf Inc. (DBD) Financial Data

Diebold Nixdorf Inc. has a market capitalization of $1.60B with a P/E ratio of -96.9x. The company generates $3.75B in trailing twelve-month revenue with a -0.4% profit margin.

Revenue growth is -4.6% quarter-over-quarter, while maintaining an operating margin of +9.0% and return on equity of -1.4%.

Valuation Metrics

Market Cap $1.60B
Enterprise Value $2.31B
P/E Ratio -96.9x
PEG Ratio 8.6x
Price/Sales 0.4x

Growth & Margins

Revenue Growth (YoY) -4.6%
Gross Margin +23.4%
Operating Margin +9.0%
Net Margin -0.4%
EPS Growth -74.9%

Financial Health

Cash/Price Ratio +19.5%
Current Ratio 1.3x
Debt/Equity 112.1x
ROE -1.4%
ROA +4.7%

๐Ÿ”ฅ Want More High-Potential Stock Ideas?

Join 5,000+ investors getting our research on stocks with massive upside potential.

Diebold Nixdorf Inc. logo

Diebold Nixdorf Inc. (DBD) Business Model

About Diebold Nixdorf Inc.

What They Do

Provides connected commerce solutions for various industries.

Business Model

Diebold Nixdorf generates revenue by offering a range of products and services, including automated teller machines (ATMs), point-of-sale (POS) systems, and transaction processing software. The company targets financial institutions, retailers, and service providers, enabling them to automate and digitize customer interactions while enhancing operational efficiency.

Additional Information

With a strong focus on innovation, Diebold Nixdorf is also involved in cybersecurity and cloud-based solutions to protect digital transactions. Headquartered in Ohio, the company operates on a global scale, playing a crucial role in the evolution of secure transaction environments.

Company Information

Sector

Technology

Industry

Software - Application

Employees

21,000

CEO

Mr. Octavio Marquez

Country

United States

IPO Year

1981

Diebold Nixdorf Inc. (DBD) Latest News & Analysis

DBD stock latest news image
Quick Summary

Diebold Nixdorf (DBD) is currently attracting attention from Zacks.com users, highlighting the need for investors to consider factors affecting its stock potential.

Why It Matters

Increased attention from Zacks.com users may indicate growing investor interest, potentially influencing Diebold Nixdorf's stock performance and volatility.

Source: Zacks Investment Research
Market Sentiment: Positive
DBD stock latest news image
Quick Summary

Diebold Nixdorf (DBD) is currently a stock of interest among Zacks.com users, prompting further exploration of its future performance.

Why It Matters

Increased attention from Zacks.com users may signal potential volatility or opportunity in Diebold Nixdorf's stock, influencing trading strategies and investor sentiment.

Source: Zacks Investment Research
Market Sentiment: Positive
DBD stock latest news image
Quick Summary

Value stocks may be a compelling option for investors during market volatility, as they often have strong fundamentals despite recent poor performance, unlike riskier growth stocks.

Why It Matters

Value stocks may outperform during market volatility, offering potential stability and returns compared to growth stocks, which can be more affected by market fluctuations.

Source: MarketBeat
Market Sentiment: Positive
DBD stock latest news image
Quick Summary

Diebold Nixdorf (NYSE: DBD) will hold its Q4 2024 Earnings Conference Call on February 12, 2025, at 8:30 AM ET, featuring key executives and analysts.

Why It Matters

Diebold Nixdorf's upcoming earnings call will provide insights into its financial performance and strategic direction, influencing investor sentiment and stock valuation.

Source: Seeking Alpha
Market Sentiment: Neutral
DBD stock latest news image
Quick Summary

Diebold Nixdorf (NYSE: DBD) reported its Q4 and full-year 2024 financial results and announced a $100 million share repurchase program. More details are available on their website.

Why It Matters

Diebold Nixdorf's $100 million share repurchase program signals confidence in its financial health and can enhance shareholder value by reducing outstanding shares.

Source: PRNewsWire
Market Sentiment: Neutral
DBD stock latest news image
Quick Summary

Diebold Nixdorf reported quarterly earnings of $0.97 per share, below the Zacks estimate of $1.18, and down from $3.02 per share a year earlier.

Why It Matters

Diebold Nixdorf's earnings miss and significant year-over-year decline signal potential operational issues, likely impacting stock performance and investor confidence.

Source: Zacks Investment Research
Market Sentiment: Negative

Frequently Asked Questions About DBD Stock

What is Diebold Nixdorf Inc.'s (DBD) stock forecast for 2025?

Based on our analysis of 8 Wall Street analysts, Diebold Nixdorf Inc. (DBD) has a median price target of $70.00. The highest price target is $80.00 and the lowest is $60.00.

Is DBD stock a good investment in 2025?

According to current analyst ratings, DBD has 2 Buy ratings, 0 Hold ratings, and 0 Sell ratings. The stock is currently trading at $42.64. Always conduct your own research and consider your investment goals before making investment decisions.

What is the long-term price prediction for DBD stock?

Wall Street analysts predict DBD stock could reach $70.00 in the next 12 months. This represents a 64.2% increase from the current price of $42.64. Please note that this is a projection by Wall Street analysts and not a guarantee.

What is Diebold Nixdorf Inc.'s business model?

Diebold Nixdorf generates revenue by offering a range of products and services, including automated teller machines (ATMs), point-of-sale (POS) systems, and transaction processing software. The company targets financial institutions, retailers, and service providers, enabling them to automate and digitize customer interactions while enhancing operational efficiency.

What is the highest forecasted price for DBD Diebold Nixdorf Inc.?

The highest price target for DBD is $80.00 from Matthew Summerville at DA Davidson, which represents a 87.6% increase from the current price of $42.64.

What is the lowest forecasted price for DBD Diebold Nixdorf Inc.?

The lowest price target for DBD is $60.00 from at , which represents a 40.7% increase from the current price of $42.64.

What is the overall DBD consensus from analysts for Diebold Nixdorf Inc.?

The overall analyst consensus for DBD is bullish. Out of 8 Wall Street analysts, 2 rate it as Buy, 0 as Hold, and 0 as Sell, with a median price target of $70.00.

How accurate are DBD stock price projections?

Stock price projections, including those for Diebold Nixdorf Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.

Important Disclaimer

The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.

Last updated: March 16, 2025 8:36 AM UTC